Key facts
- This page summarizes Susan Eylward's Form 4 filing for Imunon, Inc. (IMNN).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 21 Jul 2026, 16:15.
Susan Eylward - 17 Jul 2026 Form 4 Insider Report for Imunon, Inc. (IMNN)
- Reporting relationship
- General Counsel and Corp Sec
- Issuer ticker
- IMNN
- Reported as of
- 17 Jul 2026
- Net transaction value
- -$3,830
- SEC form
- 4
- Accepted by SEC
- 21 Jul 2026, 16:15:47 UTC
- Prior SEC filing
- 07 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Susan Eylward
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Susan Eylward filed Form 4 for Imunon, Inc. (IMNN) on 21 Jul 2026.
Change
- Previous filing in this sequence was filed on 07 Jul 2026.
- Current net transaction value: -$3,830.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002039135
Primary reporting owner
Eylward Susan
- Relationship
- General Counsel and Corp Sec
- Address
- C/O IMUNON, INC., 997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE
- Signature
- /s/ Susan Eylward
- Signature date
- 21 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IMNN
transaction
Common Stock
Award
- Transaction value
- Shares
- +2,150
- Change %
- +74%
- Price
- $1.83*
- Shares after
- 5,046
- Date
- 17 Jul 2026
- Ownership
- Direct
- Footnotes
- F1
IMNN
transaction
Common Stock
Sale
- Transaction value
- $3,830
- Shares
- -2,150
- Change %
- -43%
- Price
- $1.78
- Shares after
- 2,896
- Date
- 20 Jul 2026
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Stock granted in lieu of cash for portion of base salary
Footnote F2
Reflects a weighted average sale price of $1.7816 per share, at prices ranging from $1.76 to $1.79 per share. The reporting person will provide, upon request by the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price.